Search Results - Craig Fancourt
- Showing 1 - 3 results of 3
-
1
Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients by Andreas H. Groll, Johannes H. Schulte, Bülent Antmen, Christopher Fraser, Valerie Teal, Barbara Haber, Luzelena Caro, Jacqueline B. McCrea, Craig Fancourt, Mayankbhai Patel, Karsten Menzel, Cyrus Badshah
Published 2024Artigo -
2
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML) by Farhad Ravandi, Ivana Gojo, Mrinal M. Patnaik, Mark D. Minden, Hagop M. Kantarjian, Amy O. Johnson‐Levonas, Craig Fancourt, Raymond W. Lam, Mary Jones, Clayton D. Knox, Shelonitda Rose, Payal Patel, Raoul Tibes
Published 2016Artigo -
3
Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors by Andrew J. Wagner, Udai Banerji, Amit Mahipal, Neeta Somaiah, Heather A. Hirsch, Craig Fancourt, Amy O. Johnson‐Levonas, Raymond W. Lam, Amy Meister, Giuseppe Lo Russo, Clayton D. Knox, Shelonitda Rose, David S. Hong
Published 2017Artigo
Search Tools:
Related Subjects
Adverse effect
Internal medicine
Medicine
Biology
Gastroenterology
Pharmacokinetics
Pharmacology
Tolerability
Astrobiology
Chemotherapy
Clinical trial
Cmax
Cytomegalovirus
Environmental health
Genetics
Haematopoiesis
Hematopoietic cell
Herpesviridae
Human immunodeficiency virus (HIV)
Immunology
Leukopenia
Nausea
Neutropenia
Pharmacodynamics
Phases of clinical research
Population
Rash
Refractory (planetary science)
Regimen
Stem cell